More recently, we have provided evidence that a novel HDAC6 inhibitor, MPT0B291, inhibits the growth of stem-like/drug-resistant GBM cells and has better BBB permeability values than caffeine [23]. This evidence concerns the gene HDAC6 and glioblastoma.